Vanessa Behrana Jensen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Vanessa Behrana Jensen

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of the American Veterinary Medical Association|March 29, 2022

Pathology in PracticeVanessa Behrana Jensen, Alan F Humphreys, Laura R Pageon, et al.

International Journal of Cancer|November 5, 2020

Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcomaMarlene Hennessy, Andrew Wahba, Kumar Felix, et al.

Blood Cancer Journal|October 22, 2024

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemiaRonghua Zhang, Priyanka Khare, Priyanka Banerjee, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of the American Veterinary Medical Association|March 29, 2022

Pathology in PracticeVanessa Behrana Jensen, Alan F Humphreys, Laura R Pageon, et al.

International Journal of Cancer|November 5, 2020

Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcomaMarlene Hennessy, Andrew Wahba, Kumar Felix, et al.

Blood Cancer Journal|October 22, 2024

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemiaRonghua Zhang, Priyanka Khare, Priyanka Banerjee, et al.

Pageof 1